Updated Covid Vaccine US Rollout Hit by Insurance Coverage Delays - What It Means?
Portfolio Pulse from Vandana Singh
The US rollout of updated COVID-19 vaccines by Pfizer Inc/BioNTech SE and Moderna Inc is facing temporary insurance coverage delays. The delays are due to insurers updating their policies to incorporate the new vaccines. CVS Health Corp and Elevance Health Inc have confirmed these delays but reassure that vaccines can be accessed at no cost through insurance plans. The rollout coincides with a shift in vaccine coverage, with manufacturers now selling vaccines directly to healthcare providers.
September 20, 2023 | 6:15 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
BioNTech's updated COVID-19 vaccine is part of the US rollout facing insurance coverage delays. However, the vaccines can still be accessed at no cost through insurance plans.
While the insurance coverage delays may initially cause some concern, the assurance that vaccines can be accessed at no cost through insurance plans should mitigate any significant negative impact on BioNTech's stock.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEUTRAL IMPACT
CVS Health Corp has confirmed insurance coverage delays for the updated COVID-19 vaccines but reassures that vaccines can be accessed at no cost through insurance plans.
CVS Health's confirmation of the insurance coverage delays may initially cause some concern among investors. However, the assurance that vaccines can be accessed at no cost through insurance plans should mitigate any significant negative impact on CVS Health's stock.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 90
NEUTRAL IMPACT
Elevance Health Inc has confirmed insurance coverage delays for the updated COVID-19 vaccines but reassures that vaccines can be accessed at no cost through insurance plans.
Elevance Health's confirmation of the insurance coverage delays may initially cause some concern among investors. However, the assurance that vaccines can be accessed at no cost through insurance plans should mitigate any significant negative impact on Elevance Health's stock.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 90
NEUTRAL IMPACT
Moderna's updated COVID-19 vaccine is part of the US rollout facing insurance coverage delays. However, the vaccines can still be accessed at no cost through insurance plans.
While the insurance coverage delays may initially cause some concern, the assurance that vaccines can be accessed at no cost through insurance plans should mitigate any significant negative impact on Moderna's stock.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEUTRAL IMPACT
Pfizer's updated COVID-19 vaccine is part of the US rollout facing insurance coverage delays. However, the vaccines can still be accessed at no cost through insurance plans.
While the insurance coverage delays may initially cause some concern, the assurance that vaccines can be accessed at no cost through insurance plans should mitigate any significant negative impact on Pfizer's stock.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80